GreenLight Biosciences

NASDAQ: GRNA · Real-Time Price · USD
0.30
0.00 (0.13%)
At close: Jul 21, 2023, 8:00 PM

GreenLight Biosciences Statistics

Share Statistics

GreenLight Biosciences has 151.68M shares outstanding. The number of shares has increased by null% in one year.

151.68M
n/a
n/a
n/a
n/a
29,650
4.33%

Short Selling Information

The latest short interest is 901.46K, so 0.59% of the outstanding shares have been sold short.

901.46K
0.59%
0.96%
4.71

Valuation Ratios

The PE ratio is -0.93 and the forward PE ratio is null. GreenLight Biosciences's PEG ratio is -0.03.

-0.93
n/a
24.39
n/a
3.24
-0.95
-0.03
Financial Ratio History

Enterprise Valuation

GreenLight Biosciences has an Enterprise Value (EV) of 168.12M.

26.33
-1.09
-1.23
-1.03

Financial Position

The company has a current ratio of 2.01, with a Debt / Equity ratio of 1.67.

2.01
2.01
1.67
-0.52
-0.49
-39.76

Financial Efficiency

Return on Equity is -347.58% and Return on Invested Capital is -128.36%.

-347.58%
-112.42%
-128.36%
$22,800
$-596,625
280
0.04
n/a

Taxes

1.09M
-0.66%

Stock Price Statistics

The stock price has increased by 0.17% in the last 52 weeks. The beta is 1.44, so GreenLight Biosciences's price volatility has been higher than the market average.

1.44
0.17%
0.27
0.85
59
684,804

Income Statement

In the last 12 months, GreenLight Biosciences had revenue of 6.38M and earned -167.06M in profits. Earnings per share was -1.27.

6.38M
6.38M
-163.92M
-167.06M
-153.99M
-161.84M
-1.27
Full Income Statement

Balance Sheet

The company has 68.1M in cash and 80.48M in debt, giving a net cash position of -12.38M.

68.1M
80.48M
-12.38M
-420.64M
113.69M
6.51M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -136.73M and capital expenditures -26.55M, giving a free cash flow of -163.28M.

-136.73M
-26.55M
-163.28M
-1.24
Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -2567.65% and -2616.78%.

100%
-2567.65%
-2599.67%
-2616.78%
-2412.11%
-2567.65%
-2557.61%

Dividends & Yields

GRNA does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
-107.27%
-104.85%
Dividend Details

Analyst Forecast

Currently there are no analyst rating for GRNA.

n/a
n/a
n/a
n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-9.59
2